Regulatory Comment Rare Disease Patient Community Letter to FDA Commissioner Makary Share this page 101 patient advocacy organizations request the establishment of a complementary town hall-style meeting series to strengthen engagement between the FDA and patient advocacy groups. Patient-Focused Drug Development (PFDD)